Back
Regal Rexnord Vs. MoonLake Immunotherapeutics Industry Stock Comparison
Buy
54
RRX
Regal Rexnord
Last Price:
165.79
Seasonality Move:
2.18%
Buy
83
MLTX
MoonLake Immunotherapeutics
Last Price:
53.18
Seasonality Move:
10.4%
Buy
54
Regal Rexnord (RRX)
is a Buy
Is Regal Rexnord a Buy, Sell or Hold?
- The current Regal Rexnord [RRX] share price is $165.72. The Score for RRX is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- RRX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
83
MoonLake Immunotherapeutics (MLTX)
is a Buy
Is MoonLake Immunotherapeutics a Buy, Sell or Hold?
- The current MoonLake Immunotherapeutics [MLTX] share price is $53.02. The Score for MLTX is 83, which is 66% above its historic median score of 50, and infers lower risk than normal.
- MLTX is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
RRX Stock Price Chart
What is Regal Rexnord's stock price today?
-
The Regal Rexnord share price today is $165.72
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RRX is experiencing slight buying pressure.
MLTX Stock Price Chart
What is MoonLake Immunotherapeutics's stock price today?
-
The MoonLake Immunotherapeutics share price today is $53.02
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MLTX is experiencing slight selling pressure.
RRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.75 | Buy |
| Relative Strength Index (14 RSI): | 62.4 | Buy |
| Chaikin Money Flow: | 162349 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (151.26 - 164.5) | Buy |
| Bollinger Bands (100): | (142 - 161.42) | Buy |
MLTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.36 | Buy |
| Relative Strength Index (14 RSI): | 67.83 | Buy |
| Chaikin Money Flow: | -49117 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.38 - 50.14) | Buy |
| Bollinger Bands (100): | (40.67 - 47.33) | Buy |
RRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 154.15 | Buy |
| 20-day SMA: | 157.97 | Buy |
| 50-day SMA: | 154.7 | Buy |
| 200-day SMA: | 153.07 | Buy |
| 8-day EMA: | 157.62 | Buy |
| 20-day EMA: | 156.42 | Buy |
| 50-day EMA: | 154.61 | Buy |
| 200-day EMA: | 151.41 | Buy |
MLTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 49.49 | Buy |
| 20-day SMA: | 48.24 | Buy |
| 50-day SMA: | 46.5 | Buy |
| 200-day SMA: | 48.46 | Buy |
| 8-day EMA: | 50.08 | Buy |
| 20-day EMA: | 48.49 | Buy |
| 50-day EMA: | 46.7 | Buy |
| 200-day EMA: | 45.76 | Buy |
Regal Rexnord Earnings Growth & RRX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.50 per share, an increase this year of $0.34 per share, and an increase next year of $1.99 per share.
MoonLake Immunotherapeutics Earnings Growth & MLTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.21 per share, a decrease next quarter of $0.20 per share, a decrease this year of $0.64 per share, and a decrease next year of $0.79 per share.
Regal Rexnord Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
MoonLake Immunotherapeutics Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||